Validity, reliability, and feasibility of clinical staging scales in dementia: A systematic review

91Citations
Citations of this article
128Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

New staging systems of dementia require adaptation of disease management programs and adequate staging instruments. Therefore, we systematically reviewed the literature on validity and reliability of clinically applicable, multidomain, and dementia staging instruments. A total of 23 articles describing 12 staging instruments were identified (N = 6109 participants, age 65-87). Reliability was studied in most (91%) of the articles and was judged moderate to good. Approximately 78% of the articles evaluated concurrent validity, which was good to very good, while discriminant validity was assessed in only 25%. The scales can be applied in ±15 minutes. Clinical Dementia Rating (CDR), Global Deterioration scale (GDS), and Functional Assessment Staging (FAST) have been monitored on reliability and validity, and the CDR currently is the best-evidenced scale, also studied in international perspective, and is available in 14 languages. Taking into account the increasing differentiation of Alzheimer's disease in preclinical and predementia stages, there is an urgent need for global rating scales to be refined as well. © SAGE Publications 2011.

Cite

CITATION STYLE

APA

Olde Rikkert, M. G. M., Tona, K. D., Janssen, L., Burns, A., Lobo, A., Robert, P., … Waldemar, G. (2011). Validity, reliability, and feasibility of clinical staging scales in dementia: A systematic review. American Journal of Alzheimer’s Disease and Other Dementias. SAGE Publications Inc. https://doi.org/10.1177/1533317511418954

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free